Seth Klarman · Q1 2017
Baupost Group
Portfolio at the end of Q1 2017, from the 13F filed May 25, 2017, as amended. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Cheniere Energy LNG · history | 12.1% | Q1 2014 | No change |
| Viasat VSAT · history | 9.9% | Q2 2013 or earlier | No change |
| Twenty-First Century Fox FOXA · history | 7.3% | Q3 2015 | No change |
| Colony NorthStar CLNS · history | 7.3% | Q1 2017 | Buy |
| Synchrony SYF · history | 7.1% | Q3 2016 | Reduce 15% |
| Allergan AGN · history | 6.8% | Q1 2016 | Reduce 29% |
| Qorvo QRVO · history | 5.8% | Q1 2017 | Buy |
| Dell Technologies DELL · history | 4.3% | Q3 2016 | Reduce 15% |
| PBF Energy PBF · history | 4.1% | Q3 2013 | No change |
| Theravance Biopharma TBPH · history | 4.0% | Q2 2014 | No change |
| Antero Resources AR · history | 3.9% | Q3 2014 | No change |
| Qualcomm QCOM · history | 3.5% | Q1 2017 | Buy |
| Twenty-First Century Fox FOX · history | 2.7% | Q3 2015 | No change |
| Innoviva INVA · history | 1.9% | Q2 2013 or earlier | Reduce 22% |
| Keryx Biopharmaceuticals KERX · history | 1.9% | Q1 2014 | No change |
| Veritiv VRTV · history | 1.9% | Q3 2014 | No change |
| McKesson MCK · history | 1.7% | Q4 2016 | No change |
| Forward Pharma FWP · history | 1.4% | Q4 2014 | Add 4% |
| Atara Biotherapeutics ATRA · history | 1.3% | Q4 2014 | No change |
| Cardinal Health CAH · history | 1.0% | Q4 2016 | No change |
| Express Scripts ESRX · history | 1.0% | Q1 2017 | Buy |
| Silver Run Acquisition II SRUN.U · units · history | 0.8% | Q1 2017 | Buy |
| Liberty Ventures LVNTA · history | 0.8% | Q4 2016 | No change |
| ChipMOS IMOS · history | 0.7% | Q2 2013 or earlier | No change |
| Credit Acceptance CACC · history | 0.6% | Q2 2016 | No change |
| Atlanta Braves Holdings BATRK · history | 0.6% | Q2 2016 | Reduce 33% |
| Syngenta SYT · history | 0.6% | Q4 2016 | Reduce 29% |
| Novagold Resources NG · history | 0.5% | Q2 2013 or earlier | No change |
| GTY Technology GTYH.U · units · history | 0.5% | Q4 2016 | No change |
| Cencora COR · history | 0.5% | Q4 2016 | No change |
| Permian Resources CDEV · history | 0.5% | Q4 2016 | No change |
| Paratek Pharmaceuticals PRTK · history | 0.5% | Q4 2014 | No change |
| Conyers Park Acquisition CPAA · history | 0.5% | Q3 2016 | No change |
| Theravance Biopharma TBPH.CV · convertible notes · history | 0.4% | Q4 2016 | No change |
| Cascadian Therapeutics CASC · history | 0.4% | Q2 2016 | Add 109% |
| American International Group AIG.WS · warrants · history | 0.3% | Q2 2013 or earlier | Reduce 51% |
| Saban Capital Acquisition SCAC · history | 0.3% | Q4 2016 | No change |
| Innoviva INVA.CV · convertible notes · history | 0.3% | Q3 2014 | Reduce 51% |
| Sunrun RUN · history | 0.2% | Q3 2015 | No change |
| Orexigen Therapeutics OREX · history | 0.1% | Q3 2015 | No change |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | No change |
| Conyers Park Acquisition CPAA.WS · warrants · history | 0.0% | Q3 2016 | No change |
| Saban Capital Acquisition SCAC.WS · warrants · history | 0.0% | Q4 2016 | No change |
| 43 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2016, adjusted for stock splits.
Sector weighting
| Health care | 23.2% | |
|---|---|---|
| Energy | 20.6% | |
| Media & telecom | 20.5% | |
| Financials & real estate | 16.9% | |
| Technology | 14.9% | |
| Industrials | 2.0% | |
| Materials | 1.2% | |
| Consumer discretionary | 0.8% |
What changed from Q4 2016
- Buy Colony NorthStar CLNS 7.3% of the 13F
- Buy Qorvo QRVO 5.8% of the 13F
- Buy Qualcomm QCOM 3.5% of the 13F
- Buy Express Scripts ESRX 1.0% of the 13F
- Buy Silver Run Acquisition II SRUN.U 0.8% of the 13F
- Add 4% Forward Pharma FWP 1.0% → 1.4%
- Add 109% Cascadian Therapeutics CASC 0.2% → 0.4%
- Reduce 15% Synchrony SYF 9.8% → 7.1%
- Reduce 29% Allergan AGN 9.4% → 6.8%
- Reduce 15% Dell Technologies DELL 4.8% → 4.3%
- Reduce 22% Innoviva INVA 2.1% → 1.9%
- Reduce 33% Atlanta Braves Holdings BATRK 0.8% → 0.6%
- Reduce 29% Syngenta SYT 0.8% → 0.6%
- Reduce 51% American International Group AIG.WS 0.8% → 0.3%
- Reduce 51% Innoviva INVA.CV 0.5% → 0.3%
- Sell NorthStar Asset Management NSAM was 3.6%
- Sell NorthStar Realty Finance NRF was 2.9%
- Sell Colony Financial CLNY was 1.8%
- Sell Atlanta Braves Holdings BATRA was 0.2%
- Sell Liberty Expedia LEXEA was 0.2%
- Sell Citigroup C.WS was 0.1%